BB Biotech AG (id:13037 BION)
35.95 CHF
Opening hours: 09:00 - 17:20 (Central European Standard Time: 11/22/2024 3:01:03 AM)
Exchange closed, opens in 5 hours 58 minutes
About BB Biotech AG
Market Capitalization 1.99B
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Headquarters (address) |
Seestrasse 16 Küsnacht CH-8700 Switzerland |
Phone | 41 44 2676700 |
Website | https://www.bbbiotech.ch/en/bb-biotech/ |
Employees | 10 |
Sector | Healthcare |
Industry | Biotechnology |
Ticker | BION |
Exchange | Swiss Stock Exchange |
Currency | CHF |
52 week range | 35.45 - 49.80 |
Market Capitalization | 1.99B |
Dividend yield forward | 22.22 % |
Dividend yield forward Switzerland (ID:153, base:169) | 13.52 % |
P/E trailing | 15.85 |
P/E forward | 9.31 |
Price/Sale | -9.97 |
EPS | -3.77 |
EPS Switzerland (ID:153, base:185) | 29.31 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: BB Biotech AG has raised their dividend 22.22 years in a row. This is below the 41125.084400 year average in the 'Biotechnology' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: BB Biotech AG has raised their dividend 12.22 years in a row. This is above the 10.156100 year average in the 'Biotechnology' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: BB Biotech AG has raised their dividend 22.22 years in a row. This is below the 41125.084400 year average in the 'Biotechnology' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: BB Biotech AG has raised their dividend 12.22 years in a row. This is above the 10.156100 year average in the 'Biotechnology' industry